Jack W Singer Selected Research

Combination Drug Therapy (Combination Chemotherapy)

7/2009

Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack W Singer Research Topics

Disease

15	Neoplasms (Cancer) 11/2018 - 10/2003
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 07/2005
7	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 01/2016
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2016 - 03/2005
4	Cardiotoxicity 07/2014 - 11/2011
3	Leukemia 11/2018 - 08/2006
3	Cytopenia 01/2018 - 12/2016
3	Thrombocytopenia (Thrombopenia) 01/2018 - 07/2012
3	Neutropenia 07/2012 - 12/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018 - 01/2016
2	Necrosis 01/2018 - 04/2005
2	Disease Progression 05/2017 - 12/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016 - 01/2016
2	Lymphoma (Lymphomas) 11/2011 - 07/2005
2	Alopecia (Baldness) 06/2008 - 12/2005
2	Multiple Myeloma 04/2005 - 12/2003
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Inflammation (Inflammations) 09/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Splenomegaly 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Anemia 01/2018
1	Pneumonia (Pneumonitis) 05/2017
1	Fever (Fevers) 05/2017
1	Heart Failure 05/2017
1	Hypotension (Low Blood Pressure) 05/2017
1	Sepsis (Septicemia) 05/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2016
1	Weight Loss (Weight Reduction) 07/2014
1	Neoplasm Metastasis (Metastasis) 07/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2008
1	Hypersensitivity (Allergy) 06/2008

Drug/Important Bio-Agent (IBA)

8	pixantrone (BBR 2778)IBA 01/2020 - 04/2011
8	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2019 - 01/2016
5	paclitaxel poliglumex (XYOTAX)IBA 12/2010 - 03/2005
5	Paclitaxel (Taxol)FDA LinkGeneric 06/2008 - 03/2005
5	2-acylglycerophosphate acyltransferaseIBA 11/2006 - 10/2003
3	Gemcitabine FDA Link 01/2020 - 07/2008
3	ruxolitinibIBA 01/2019 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2014 - 04/2011
3	AnthraquinonesIBA 07/2014 - 07/2012
3	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2013 - 11/2011
3	Protein Isoforms (Isoforms)IBA 08/2006 - 10/2003
2	Rituximab (Mabthera)FDA Link 01/2020 - 11/2011
2	Interleukin-1 Receptor-Associated KinasesIBA 11/2018 - 09/2018
2	Janus Kinase 2IBA 01/2018 - 01/2016
2	AnthracyclinesIBA 02/2013 - 07/2012
2	Vinorelbine (Navelbine)FDA LinkGeneric 07/2012 - 07/2008
2	Cathepsin BIBA 03/2007 - 01/2006
2	CT-32228IBA 08/2006 - 07/2005
2	Glutamic Acid (Glutamate)FDA Link 12/2005 - 03/2005
2	Phosphatidic Acids (Phosphatidic Acid)IBA 12/2003 - 10/2003
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 01/2019
1	fedratinibIBA 01/2019
1	Janus Kinase InhibitorsIBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2018
1	Interleukin-1 (Interleukin 1)IBA 09/2018
1	Telmisartan (Micardis)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Keratin-18 (Keratin 18)IBA 01/2018
1	Janus Kinase 1IBA 01/2018
1	CytokinesIBA 01/2018
1	AngiotensinsIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2016
1	Tyrosine Kinase InhibitorsIBA 10/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Decitabine FDA Link 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	tosedostatIBA 01/2016
1	adriamycinolIBA 02/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2013
1	Superoxides (Superoxide)IBA 02/2013
1	Ifosfamide FDA LinkGeneric 07/2012
1	Etoposide (VP 16)FDA LinkGeneric 07/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2011
1	fludarabineIBA 11/2011
1	Prednisone (Sone)FDA LinkGeneric 04/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2011
1	Vincristine (Oncovin)FDA LinkGeneric 04/2011
1	PlatinumIBA 02/2010
1	DNA (Deoxyribonucleic Acid)IBA 02/2010
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2009
1	AlbuminsIBA 07/2009
1	Cisplatin (Platino)FDA LinkGeneric 04/2009

Therapy/Procedure

7	Therapeutics 01/2019 - 10/2003
4	Drug Therapy (Chemotherapy) 12/2016 - 06/2008
2	Salvage Therapy 02/2013 - 07/2012
2	Premedication 06/2008 - 12/2005
1	Stem Cell Transplantation 01/2020
1	Intraperitoneal Injections 07/2014
1	Combination Drug Therapy (Combination Chemotherapy) 07/2009